Free Trial
NASDAQ:NLSP

NLS Pharmaceutics (NLSP) Stock Price, News & Analysis

NLS Pharmaceutics logo
$2.25 +0.05 (+2.27%)
Closing price 04:00 PM Eastern
Extended Trading
$2.24 0.00 (-0.22%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NLS Pharmaceutics Stock (NASDAQ:NLSP)

Key Stats

Today's Range
$2.15
$2.25
50-Day Range
$1.61
$2.90
52-Week Range
$1.30
$15.59
Volume
43,389 shs
Average Volume
851,760 shs
Market Capitalization
$8.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NLSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter.

NLSP Stock News Headlines

NLS Pharmaceutics (NASDAQ:NLSP) Upgraded at Wall Street Zen
[ATTENTION] This Crypto Rocket Is About Launch…
Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.
NLS Pharmaceutics CEO Issues Letter to Shareholders
See More Headlines

NLSP Stock Analysis - Frequently Asked Questions

NLS Pharmaceutics' stock was trading at $2.11 at the start of the year. Since then, NLSP shares have increased by 6.6% and is now trading at $2.25.

NLS Pharmaceutics (NLSP) raised $20 million in an IPO on Friday, January 29th 2021. The company issued 3,600,000 shares at $5.00-$6.00 per share. Maxim Group LLC acted as the underwriter for the IPO and Brookline Capital (A division of Arcadia Securities) was co-manager.

Shares of NLSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NLS Pharmaceutics investors own include Intel (INTC), Meta Platforms (META), Immunic (IMUX), Seres Therapeutics (MCRB), NVIDIA (NVDA), Tesla (TSLA).

Company Calendar

Today
7/16/2025
Next Earnings (Estimated)
8/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NLSP
CIK
1783036
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.69
Quick Ratio
2.69

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.37) per share
Price / Book
-6.03

Miscellaneous

Outstanding Shares
3,600,000
Free Float
3,008,000
Market Cap
$8.03 million
Optionable
Not Optionable
Beta
0.18
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:NLSP) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners